Dr. Atit Dharia

image

Dr. Atit Dharia

Nephrology - Consultant

Dr. Atit Dharia  is a Consultant Nephrologist with 10 years of experience and expertise in Acute Kidney Injury, Kidney Transplant, Critical Care Nephrology, Electrolyte and Acid-Base Disorders, Diabetic Nephropathy, Cardio-Renal Syndrome, Hemodialysis, and Peritoneal Dialysis. He holds an M.B.B.S., M.D. (Medicine), and DNB in Nephrology, providing expert care in both acute and chronic kidney conditions.

Experience : 10 years 

For appointment : 022 66660000

Email address : [email protected]

 

Request an Appointment Call
  • M.B.B.S.
  • M.D. (Medicine)
  • DNB Nephrology  

With over 32 years of clinical experience, including 16 years of dedicated service at Lilavati Hospital, Dr. Shah has successfully performed nearly 6,500 urological procedures. He received specialized training in endourology at the Mayo Clinic in 1987 under the mentorship of Dr. Joseph Segura, a pioneer in the field. Further advancing his skills, Dr. Shah obtained robotic surgery certification in 2012 and completed additional training in Retrograde Intrarenal Surgery (RIRS) in both the USA and France. His extensive experience and continuous learning have solidified his reputation as a leader in urology.

Publications: 

  • Dharia A and Hande V “Approach to Upper GI Bleed” – Journal of Marine Medical Society, June 2012.  
  • Dharia A, Sridhar V, Perlis N, Cherney D. Case - Reflex anuria: A rare complication of retrograde pyelography. Can Urol Assoc J. 2021 Jul;15(7):E380-E382. doi:10.5489/cuaj.7036. PMID: 33382376; PMCID: PMC8279234.  
  • Dharia A, Boulet J, Sridhar VS, Kitchlu A. Cancer Screening in Solid Organ Transplant Recipients: A Focus on Screening Liver, Lung, and Kidney Recipients for Cancers Related to the Transplanted Organ. Transplantation. 2022 Jan 1;106(1):e64-e65. doi: 10.1097/TP.0000000000003773. PMID: 33795594.  
  • Liu H, Sridhar VS, Boulet J, Dharia A, Khan A, Lawler PR, Cherney DZI. Cardiorenal protection with SGLT2 inhibitors in patients with diabetes mellitus: from biomarkers to clinical outcomes in heart failure and diabetic kidney disease. Metabolism. 2022 Jan;126:154918. doi:10.1016/j.metabol.2021.154918. Epub 2021 Oct 23. PMID: 34699838.  
  • Dharia AA, Huang M, Nash MM, Dacouris N, Zaltzman JS, Prasad GVR. Post-transplant outcomes in recipients of living donor kidneys and intended recipients of living donor kidneys. BMC Nephrol. 2022 Mar 5;23(1):97. doi:10.1186/s12882-022-02718-6. PMID: 35247959; PMCID: PMC8898413.  
  • Yau K, Dharia A (co-first author), Alrowiyti I, Cherney DZI. Prescribing SGLT2 Inhibitors in Patients With CKD: Expanding Indications and Practical Considerations. Kidney Int Rep. 2022 May 5;7(7):1463-1476. doi: 10.1016/j.ekir.2022.04.094. PMID: 35812300  
  • Dharia A, Khan A, Sridhar VS, Cherney DZI. SGLT2 Inhibitors: The Sweet Success for Kidneys. Annu Rev Med. 2023 Jan 27;74:369-384. doi: 10.1146/annurev-med-042921-102135. PMID: 36706745.  
  • Lytvyn Y, Felfeli T, Dubrofsky L, Dharia A et al. Diabetic retinopathy screening integrated in a multidisciplinary diabetes care clinic: a pilot project [published online ahead of print, 2023 Apr 3]. Can J Ophthalmol. 2023;S0008-4182(23)00067-4. doi:10.1016/j.jcjo.2023.02.014.  
  • Ray S, Yousuf A, Dharia A, et al. Outcomes of pancreas transplantation in patients with underlying inflammatory bowel disease: a retrospective case series. Ann Med Surg (Lond). 2023;85(4):732-737. Published 2023 Mar 27. doi:10.1097/MS9.0000000000000408.
  • Wednesday : 05:00 pm - 06:00 pm
Book an appointment
Take a second opinion
Anni is here to help you !